![Dylan Morris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dylan Morris
Président chez
Vecprobio Inc.
Profil
Dylan Morris is the founder of Integrated Plasmonics Corp., founded in 2011.
Current jobs include Chairman at Vecprobio Inc., Managing Director at Insight Venture Management LLC since 2021, Director at Deciduous Therapeutics, Inc., Director at Dyno Therapeutics, Inc., Director at Unlearn.ai, Inc. since 2022, Board Of Director at Gameto, Inc. since 2022, Director at ArrePath, Inc., Board Of Director at ImmuneBridge, Inc. since 2023, Board Of Director at DEM BioPharma, Inc. since 2022, Board Of Director at Capacity Bio, Inc. since 2022, Board Of Director at Superluminal Medicines, Inc. since 2023, and Board Of Directot at Switch Therapeutics, Inc. since 2020.
Former job includes General Partner at CRV LLC from 2017 to 2021.
Postes actifs de Dylan Morris
| Sociétés | Poste | Début |
|---|---|---|
Deciduous Therapeutics, Inc.
 Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Directeur/Membre du Conseil | - |
Dyno Therapeutics, Inc.
 Dyno Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a biotechnology company that uses artificial intelligence for gene therapy | Directeur/Membre du Conseil | - |
Unlearn.AI, Inc.
 Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine | Directeur/Membre du Conseil | 19/04/2022 |
ArrePath, Inc.
 ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Directeur/Membre du Conseil | - |
Vecprobio Inc.
 Vecprobio Inc. Packaged SoftwareTechnology Services Develops manufacturing technologies and tools for gene therapy | Président | - |
Insight Venture Management LLC
 Insight Venture Management LLC Investment ManagersFinance Insight Partners invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early, growth and later stage capital requirements. | Private Equity Investor | 01/01/2021 |
Switch Therapeutics, Inc.
 Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops precision RNA interference medicines for central nervous system diseases | Directeur/Membre du Conseil | 01/01/2020 |
DEM BioPharma, Inc.
 DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Directeur/Membre du Conseil | 01/01/2022 |
Capacity Bio, Inc.
 Capacity Bio, Inc. BiotechnologyHealth Technology Engages in targeting fundamental biology for radical therapeutic benefits | Directeur/Membre du Conseil | 01/01/2022 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Dylan Morris
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Integrated Plasmonics Corp.
 Integrated Plasmonics Corp. SemiconductorsElectronic Technology Develops and manufactures integrated plasmonic surface-sensing devices for spectrographically examine biochemical samples | Electronic Technology |
Insight Venture Management LLC
Insight Venture Management LLC Investment ManagersFinance Insight Partners invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early, growth and later stage capital requirements. | Finance |
CRV LLC
 CRV LLC Investment ManagersFinance Charles River Ventures invests in companies located in the United States. The firm focuses on communications & technology, enterprise software/services and media/entertainment sectors. It provides financing for seed and early stage capital requirements with an investment size of $ 0.025 to 5 million. It acts as the lead investor. | Finance |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Health Technology |
Dyno Therapeutics, Inc.
Dyno Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a biotechnology company that uses artificial intelligence for gene therapy | Technology Services |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine | Technology Services |
Switch Therapeutics, Inc.
Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops precision RNA interference medicines for central nervous system diseases | Health Technology |
Gameto, Inc.
 Gameto, Inc. BiotechnologyHealth Technology Develops biotechnologies in female reproductive solutions | Health Technology |
ImmuneBridge, Inc.
 ImmuneBridge, Inc. BiotechnologyHealth Technology Develops allogeneic immunotherapies for cancer | Health Technology |
ArrePath, Inc.
ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Health Technology |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Commercial Services |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Engages in targeting fundamental biology for radical therapeutic benefits | Health Technology |
Vecprobio Inc.
Vecprobio Inc. Packaged SoftwareTechnology Services Develops manufacturing technologies and tools for gene therapy | Technology Services |
Superluminal Medicines Inc
 Superluminal Medicines Inc BiotechnologyHealth Technology Operates as a generative biological and chemical company | Health Technology |
